Endometrioid carcinomas are pleiotropic and can be either estrogen receptor (ER) positive or negative, and display variable alterations in p53, PTEN, Ras, and E-cadherin[4]. The gene discussed is ESR1; the disease is endometrioid adenocarcinoma.